These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 188564)

  • 21. Low density lipoprotein metabolism in type IV and type V hyperlipoproteinemia.
    Brook JG; Torsvik H; Lees RS; McCluskey MA; Feldman HA
    Metabolism; 1979 Jan; 28(1):4-8. PubMed ID: 215869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of type III hyperlipoproteinemia by chromatography of plasma lipoproteins on columns containing agarose.
    Shepherd J; Packard CJ; Dryburgh FJ; Third JL
    Clin Chem; 1975 Dec; 21(13):1887-9. PubMed ID: 172260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of thyroid-stimulating hormone in hyperlipoproteinemia.
    Vessby B; Wide L
    Clin Chim Acta; 1975 Jul; 62(2):293-7. PubMed ID: 168013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay.
    Kushwaha RS; Hazzard WR; Wahl PW; Hoover JJ
    Ann Intern Med; 1977 Nov; 87(5):509-16. PubMed ID: 200160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.
    Patsch JR; Jackson RL; Gotto AM
    Klin Wochenschr; 1977 Nov; 55(21):1025-30. PubMed ID: 200792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-density-lipoprotein apoprotein B in plasma as measured by radial immunodiffusion and rocket immunoelectrophoresis.
    Havekes L; Hemmink J; de Wit E
    Clin Chem; 1981 Nov; 27(11):1829-33. PubMed ID: 6794945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dietary saturated and polyunsaturated fat on the metabolism of apolipoproteins A-I and B. Study of a patient with type IIb hyperlipoproteinaemia.
    Shepherd J; Packard CJ; Gotto AM; Taunton OD
    Clin Chim Acta; 1978 Aug; 87(3):395-404. PubMed ID: 209911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
    Miyake N; Iizuka K
    Rinsho Byori; 2002 Jun; 50(6):605-12. PubMed ID: 12166081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catabolism of alpha2-and beta-very low density lipoproteins in normal and hyperlipidemic subjects.
    Kushwaha RS; Haffner SM; Foster DM; Hazzard WR
    Trans Assoc Am Physicians; 1981; 94():253-60. PubMed ID: 7344223
    [No Abstract]   [Full Text] [Related]  

  • 34. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia].
    Nowicka G; Kłosiewicz-Latoszek L
    Wiad Lek; 1985 Aug; 38(16):1179-84. PubMed ID: 4082589
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.
    Gotto AM; Brown WV; Levy RI; Birnbaumer ME; Fredrickson DS
    J Clin Invest; 1972 Jun; 51(6):1486-94. PubMed ID: 4336942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in rabbit lipoprotein properties by dietary cholesterol, and saturated and polyunsaturated fats.
    Stange E; Agostini B; Paenberg J
    Atherosclerosis; 1975; 22(1):125-48. PubMed ID: 168909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of dietary-fat saturation on the metabolism of apolipoproteins A-I, B and C in a type-IIb hyperlipoproteinaemic subject [proceedings].
    Shepherd J; Packard C; Morgan G; Taunton D; Gotto A
    Biochem Soc Trans; 1978; 6(3):592-6. PubMed ID: 208891
    [No Abstract]   [Full Text] [Related]  

  • 38. The beta-lipoprotein doublet in type 3 hyperlipoproteinemia.
    Papadopoulos NK; Herbert PN
    Clin Chem; 1977 Jun; 23(6):978-81. PubMed ID: 192490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
    Utermann G; Jaeschke M; Menzel J
    FEBS Lett; 1975 Aug; 56(2):352-5. PubMed ID: 169165
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of carbohydrate, fat and total energy adjustment of Fredrickson's type IIb hyperlipoproteinaemia.
    Watermeyer GS; Manning E
    S Afr Med J; 1977 Jan; 51(3):71-3. PubMed ID: 189446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.